Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer

Condition:   Locally Advanced Head and Neck Cancer
Intervention:   Drug: Pembrolizumab
Sponsor:   Kuwait Cancer Control Center
Not yet recruiting

https://ift.tt/2s9vqIz